Skip to main content
. 2021 Jul 23;100(29):e26737. doi: 10.1097/MD.0000000000026737

Figure 2.

Figure 2

Survival analysis after the development of cutaneous metastasis in all cancer patients, with median overall survival of 9.21 months (95% confidence interval, 4.75–83.38 months).